Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
A resting heart rate in the 50s to low 60s is expected on metoprolol and is usually not dangerous by itself, but a rate consistently below 50 beats per minute, and especially below 40, is generally considered too slow and needs prompt medical review. Warning signs matter more than the number alone: dizziness, near fainting, fainting, unusual fatigue, shortness of breath, chest pain, or confusion at any heart rate call for urgent attention. Your safe threshold also depends on your dose, kidney function, age, fitness level, and other rate slowing medications such as diltiazem, verapamil, digoxin, or amiodarone, so there are several important factors to consider before deciding whether to skip a dose. Never stop metoprolol abruptly, since sudden withdrawal can trigger rebound rapid heart rate, high blood pressure, or chest pain; see the complete details below for the specific numbers, symptoms, and situations that should prompt a call to your prescriber versus emergency care.
Because bradycardia on a beta blocker can range from harmless to a sign of a conduction problem, it helps to sort your symptoms quickly and know which level of care fits, and a free, instant online symptom check can help you organize what you are feeling and understand your next steps in minutes.
Last reviewed for medical accuracy: 09/14/2026
Metoprolol is a beta-blocker commonly prescribed to lower blood pressure, control chest pain (angina), and manage certain heart rhythm problems. One of its main effects is to slow down your heart rate. While this can be beneficial, it’s important to know how slow is too slow—and what to do if you notice symptoms.
Because everyone responds differently, your “target” heart rate on metoprolol may vary. Factors like age, fitness level, other medical conditions and the dose you’re taking all play a role.
There’s no one-size-fits-all number, but these guidelines can help you know when to worry:
• 50–59 bpm
– Usually safe if you feel well.
– Common in people taking metoprolol.
• 40–49 bpm
– May be concerning if you experience symptoms like lightheadedness, weakness or shortness of breath.
– Consider checking again in different positions (lying down vs. sitting vs. standing).
• Below 40 bpm
– Often considered too slow for most people on beta-blockers.
– Strongly recommend contacting your healthcare provider, especially if you feel unwell.
• Below 30 bpm or any heart rate accompanied by fainting
– Medical emergency—call 911 or go to the nearest emergency department immediately.
Even if you stay above 50 bpm, watch for any of these warning signs:
Keep a symptom and heart rate diary.
Use a reliable method.
Stay consistent.
First, don’t panic. Many people on metoprolol have resting rates in the 50s and feel fine.
If you feel mild symptoms and your rate is 40–49 bpm:
• Sit or lie down until you feel better.
• Recheck your rate after a few minutes.
• Note the dose and timing of your last metoprolol tablet.
If your heart rate is below 40 bpm or you have moderate to severe symptoms:
• Stop any strenuous activity.
• Reach out to your prescriber or primary care office.
If you faint, have chest pain, severe shortness of breath or confusion:
• Call 911 or go to the nearest emergency department.
Not sure whether your symptoms are serious? You might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Always let your healthcare provider know if you experience:
Your doctor may:
This information is intended to help you understand how slow is too slow on metoprolol, but it can’t replace personalized medical advice. Always speak to a doctor about anything that could be life-threatening or serious.
(References)
* Ahuja RC, Sinha N, Saran RK, Jain AK, Hasan M. Digoxin or verapamil or metoprolol for heart rate control in patients with mitral stenosis--a randomised cross-over study. Int J Cardiol. 1989 Dec;25(3):325-31. doi: 10.1016/0167-5273(89)90223-4. PMID: 2613380.
* Scheinman MM, Hess DS. New antiarrhythmic drugs. Am J Surg. 1983 Jun;145(6):724-32. doi: 10.1016/0002-9610(83)90129-0. PMID: 6407348.
* Kontopoulos AG, Athyros VG, Papageorgiou AA, Papadopoulos GV, Avramidis MJ, Boudoulas H. Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients. Am J Cardiol. 1996 Feb 1;77(4):242-6. doi: 10.1016/s0002-9149(97)89386-1. PMID: 8607401.
* Rolfo F, Bobbio M, Angeli F, Cavallini C. [The POISE study]. G Ital Cardiol (Rome). 2008 Dec;9(12):803-7. PMID: 19119689.
* Raju VM, Gosling OE, Morgan-Hughes G, Colliver RJ, Iyengar S, Dissanayake P, Roobottom CA. High-dose intravenous metoprolol usage for reducing heart rate at CT coronary angiography: efficacy and safety. Clin Radiol. 2014 Jul;69(7):739-44. doi: 10.1016/j.crad.2014.03.003. Epub 2014 May 10. PMID: 24824980.
* Vaillant F, Lauzier B, Ruiz M, Shi Y, Lachance D, Rivard ME, Bolduc V, Thorin E, Tardif JC, Des Rosiers C. Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia. Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H991-H1003. doi: 10.1152/ajpheart.00789.2015. Epub 2016 Aug 5. PMID: 27496881.
* Jiang J, Cong H, Zhang Y, Li Z, Tao G, Li X, Qing L, Tan N, Zhao Z, Dong Y, Ji Z, Chen Y, Ge J, He B, Sun Y, Cao K, Huo Y. Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy. Int J Med Sci. 2017;14(5):477-483. doi: 10.7150/ijms.18054. Epub 2017 Apr 9. PMID: 28539824; PMCID: PMC5441040.
* Wang S, Zou R, Cai H, Wang Y, Ding Y, Tan C, Yang M, Li F, Wang C. Heart Rate and Heart Rate Difference Predicted the Efficacy of Metoprolol on Postural Tachycardia Syndrome in Children and Adolescents. J Pediatr. 2020 Sep;224:110-114. doi: 10.1016/j.jpeds.2020.05.017. Epub 2020 May 25. PMID: 32464225.
* Rivinius R, Helmschrott M, Rahm AK, Darche FF, Thomas D, Bruckner T, Doesch AO, Katus HA, Ehlermann P. Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation. Clin Res Cardiol. 2022 Feb;111(2):141-153. doi: 10.1007/s00392-020-01692-z. Epub 2020 Jun 22. PMID: 32572551; PMCID: PMC8816306.
* Nunes MO, Witt DR, Casey SA, Stanberry LI, Caye DJ, J Chu B, Lindberg BJ, Lesser JR, Han BK. Safety, Efficacy, and Dose Protocol of Metoprolol for Heart Rate Reduction in Pediatric Outpatients Undergoing Cardiac CT Angiography. Arq Bras Cardiol. 2021 Jan;116(1):100-105. doi: 10.36660/abc.20190892. PMID: 33566972; PMCID: PMC8159495.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.